Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical evaluation of a novel plasma pTau217 electrochemiluminescence immunoassay in Alzheimer’s disease
Pia Kivisäkk, Hadia Fatima, Danielle S. Cahoon, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 19

Showing 19 citing articles:

Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p‐tau217 immunoassays
Daniel Figdore, Michael Griswold, Joshua A. Bornhorst, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 9, pp. 6506-6516
Open Access | Times Cited: 16
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
Angeliki Zarkali, George E. Thomas, Henrik Zetterberg, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
A critical appraisal of blood-based biomarkers for Alzheimer’s disease
Simone Lista, Mark Mapstone, Filippo Caraci, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102290-102290
Closed Access | Times Cited: 12
Alzheimer’s disease biomarkers and their current use in clinical research and practice
T. Hunter, Luís E. Santos, Fernanda Tovar‐Moll, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 12
Electrochemical Technology for the Detection of Tau Proteins as a Biomarker of Alzheimer’s Disease in Blood
Jianman Wang, Xing Lü, Yao He
Biosensors (2025) Vol. 15, Iss. 2, pp. 85-85
Open Access | Times Cited: 1
The Alzheimers Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study
Nicholas J. Ashton, Ashvini Keshavan, Wagner S. Brum, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Clinical decision points for two plasma p‐tau217 laboratory developed tests in neuropathology confirmed samples
Anna Mammel, Ging‐Yuek Robin Hsiung, Ali Mousavi, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2025) Vol. 17, Iss. 1
Open Access
Elevated plasma Tau-PT217 linked to decreased hippocampal functional connectivity in patients with knee osteoarthritis
Ya Wen, Mattia Cannistra, Valeria Saccà, et al.
Brain Research (2025), pp. 149478-149478
Closed Access
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho‐tau Round Robin study
Nicholas J. Ashton, Ashvini Keshavan, Wagner S. Brum, et al.
Alzheimer s & Dementia (2025)
Open Access
The Urgent and Global Need for Democratized Blood-Based Biomarker Diagnostics in Alzheimer’s Disease
Steven D. Quinn
(2025), pp. 100002-100002
Open Access
Fluid-based biomarkers for neurodegenerative diseases
Yongliang Cao, Yifei Xu, Meiqun Cao, et al.
Ageing Research Reviews (2025), pp. 102739-102739
Open Access
Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias
G. Bellomo, Lisa Vermunt, Sjors G. J. G. In ‘t Veld, et al.
(2025)
Closed Access
Development and Validation of Multiplex Assays For Lupus Nephritis Activity Biomarkers
Ellen Cody, Alyssa Sproles, James Rose, et al.
Kidney International Reports (2025)
Open Access
Clinical Application of Blood Biomarkers in Neurodegenerative Diseases—Present and Future Perspectives
Daria Krawczuk, Agnieszka Kulczynska‐Przybik, Barbara Mroczko
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8132-8132
Open Access | Times Cited: 3
An Overview of the Genes and Biomarkers in Alzheimer’s Disease
Hari Krishnan Krishnamurthy, Vasanth Jayaraman, Karthik Krishna, et al.
Ageing Research Reviews (2024), pp. 102599-102599
Open Access | Times Cited: 3
P-tau217 as a Reliable Blood-Based Marker of Alzheimer’s Disease
Roy Lai, Brenden Li, Ram Bishnoi
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1836-1836
Open Access | Times Cited: 2
Performance of plasma p-tau217 for the detection of amyloid-β positivity in a memory clinic cohort using an electrochemiluminescence immunoassay
Adam H. Dyer, Helena Dolphin, Antoinette O’Connor, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Navigating the Alzheimer’s Biomarker Landscape: A Comprehensive Analysis of Fluid-Based Diagnostics
Elsa El Abiad, Ali Al-Kuwari, Ubaida Al-Aani, et al.
Cells (2024) Vol. 13, Iss. 22, pp. 1901-1901
Open Access | Times Cited: 1
Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease pathology among cognitively impaired and unimpaired: A systematic review and meta‐analysis
Mohammad Khalafi, William Jones Dartora, Laura Beth McIntire, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 1
Alzheimer’s disease clinical decision points for two plasma p-tau217 laboratory developed tests in neuropathology confirmed samples
Anna Mammel, Ging‐Yuek Robin Hsiung, Ali Mousavi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Association of plasma BDNF and MMP-9 levels with mild cognitive impairment: a matched case-control study
Tingyu Zhang, Hang Si, Jiali Liao, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Page 1

Scroll to top